Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1371 of 3330
Next
>>
>
34251 to 34275 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.533	uM	7484.07	0.8647	0.8859	2.4739
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	2.67	uM	7484.07	0.7550	0.7852	2.4739
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	13.3	uM	7484.07	0.0601	-0.3581	2.4739
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	66.7	uM	7484.07	0.0269	-0.5360	2.4739
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.000341	uM	7484.09	0.9456	0.9583	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.00171	uM	7484.09	0.9579	0.9678	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.00853	uM	7484.09	0.8789	0.9050	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.0427	uM	7484.09	0.9519	0.9631	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.213	uM	7484.09	0.8555	0.8857	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	1.07	uM	7484.09	0.6308	0.6811	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	5.33	uM	7484.09	0.5498	0.5962	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	26.7	uM	7484.09	0.6075	0.6574	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	133	uM	7484.09	0.5130	0.5550	2.6525
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.000171	uM	7484.098	1.0338	1.0256	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.000853	uM	7484.098	0.9426	0.9553	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.00427	uM	7484.098	0.9741	0.9800	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.0213	uM	7484.098	1.0045	1.0034	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.107	uM	7484.098	0.9592	0.9684	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.533	uM	7484.098	0.7798	0.8185	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	2.67	uM	7484.098	0.6710	0.7168	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	13.3	uM	7484.098	0.2282	0.1364	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	66.7	uM	7484.098	0.0203	-0.5501	2.6137
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.000171	uM	7485.092	1.0135	1.0074	3.6408
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.000853	uM	7485.092	0.9937	0.9965	3.6408
MCF 10A	NM	Basal B	GSK1838705A	IGF1R	RTK	0.00427	uM	7485.092	0.9739	0.9855	3.6408

|<
<<
Previous
Page 1371 of 3330
Next
>>
>
34251 to 34275 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)